多发性骨髓瘤诊疗需多学科联合“量身定制”最佳方案
【中新网上海3月2日电】(记者 陈静)骨质疏松、骨痛、贫血、乏力、视力减退、病毒感染……这些看似老年人的常见症状，背后“元凶”可能是血液肿瘤——多发性骨髓瘤(multiple myeloma, MM)。
中国抗癌协会血液肿瘤整合康复专委会主任委员邱录贵2日表示，多发性骨髓瘤是一种起源于浆细胞的恶性肿瘤，好发于中老年人，其发病机制复杂，涉及多种遗传和环境因素。
邱录贵指出，多发性骨髓瘤的临床表现多样，早期症状不典型，容易被忽视或误诊为其他疾病。随着病情进展，患者会出现骨痛、贫血、乏力、感染、肾功能损害等一系列症状。
“多发性骨髓瘤的诊疗是一个复杂的过程，需要多学科联合‘量身定制’最佳治疗方案。”邱录贵强调，多学科团队应包括血液科医生、骨科医生、放射科医生、病理科医生、康复科医生等。
在治疗方面，邱录贵介绍，近年来多发性骨髓瘤的治疗取得了长足进步，包括化疗、靶向治疗、免疫治疗、干细胞移植等多种手段。其中，靶向治疗和免疫治疗的应用显著提高了患者的生存率和生活质量。
邱录贵提醒，多发性骨髓瘤患者应定期随访，密切监测病情变化。对于高危患者，应早期采取积极治疗措施，以延缓疾病进展，提高生存率。
此外，邱录贵强调，多发性骨髓瘤患者在治疗过程中应注意营养支持、心理疏导和康复锻炼。营养支持可以增强患者的免疫力，促进伤口愈合；心理疏导可以帮助患者缓解焦虑和抑郁情绪；康复锻炼可以改善患者的体力和功能状态。
英语如下：
**Headline:** Multiple Myeloma: The ‘Culprit’ Behind Common Symptoms inthe Elderly
**Keywords:** Myeloma, Multidisciplinary, Personalized
**News Content:** Multidisciplinary collaboration is needed to “tailor” the best treatment planfor multiple myeloma diagnosis and treatment
[Shanghai, March 2, China News Network] (Reporter Chen Jing) Osteoporosis, bone pain, anemia, fatigue, vision loss, viral infections… These seemingly common symptoms in the elderly may be caused by a blood tumor—multiple myeloma (MM).
Qiu Lugui, director of the Blood Tumor Integrated Rehabilitation Committee of the Chinese Anti-Cancer Association, said on the 2nd that multiple myeloma is a malignant tumor originating from plasma cells, which is common in middle-aged and elderly people. Its pathogenesis is complex, involving multiple genetic and environmental factors.
Qiu Lugui pointed out that the clinical manifestations of multiple myeloma are diverse, and the early symptoms are atypical, which can be easily overlooked or misdiagnosed as other diseases. As the disease progresses, patients may experience a series of symptoms such as bone pain, anemia, fatigue, infection, and renal impairment.
“The diagnosis and treatmentof multiple myeloma is a complex process that requires a multidisciplinary team to ‘tailor’ the best treatment plan,” Qiu Lugui emphasized. The multidisciplinary team should include hematologists, orthopedists, radiologists, pathologists, and rehabilitation physicians.
In terms of treatment, Qiu Lugui introduced that great progress has been made in the treatment of multiple myeloma in recent years, including various methods such as chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. Among them, the application of targeted therapy and immunotherapy has significantly improved the survival rate and quality of life of patients.
Qiu Lugui reminded that patients with multiple myeloma should follow up regularly and closely monitor the changes in their condition. For high-risk patients, active treatment measures should be taken early to delay disease progression and improve survival rate.
In addition, Qiu Lugui emphasized that patients with multiple myeloma should pay attention to nutritional support, psychological counseling, and rehabilitation exercises during the treatment process. Nutritional support can enhance the patient’s immunity and promote wound healing; psychological counseling can help patients relieve anxiety and depression; rehabilitation exercises can improve the patient’s physical strength and functional status.
【来源】http://www.chinanews.com/life/2024/03-02/10173266.shtml
Views: 1